Tagged with P

Pharma Merck Czech Republic’s MD reveals his plan to double Merck operations within the next five years and talks about the impact of the recent acquisition of Sigma Aldrich on the Czech Republic. You’ve assumed position as Managing Director Merck Czech Republic just over one year ago; what was the strategy…

Pharma The president of the Czech Academy of Sciences highlights the responsibility of leading scientists to consider the real life application of their academic results in addition to promoting the Czech sciences in world leading publications. Could you please briefly elaborate the history and background of the Czech Academy of Sciences?…

Pharma The following chart shows the top pharma companies in Hungary ranked by sales value. Global giant Novartis leads the way with USD 240 million of sales, followed by domestic champion Egis with USD 150 million.  Click here to read more articles and interviews from Hungary

Pharma Rafael Suarez, general manager of Ferring in Mexico, explains how the Swiss biopharmaceutical company is adapting to the recent dynamics affecting both the Mexican public and private sectors. He outlines his approach to further consolidate the Mexican affiliate, increase Ferring’s clinical research investments and manufacturing presence in Mexico. When Pharmaceutical…

Pharma As President of Biopharma Activities for Merck in France, Pierre-Henry Longeray reveals how France is the third ranked affiliate after the US and Germany for the Group; how the French culture of innovation is one of the main drivers of the business; and how Merck is shifting from a pharmaceutical…

Pharma Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important research partnerships and achievements, notably with regards to neurodegenerative diseases, and her expectations of fostering a heightened research-based relationship with the pharmaceutical industry. What have been some of the…

Pharma Axel B. Müller, managing director of Intergenerika, the Swiss generics association, reveals the penetration rate of generics in Switzerland; why generics are a safe, and smarter choice, manufactured to modern standards with affordable prices; and the threat of government forcing generic companies to benchmark their prices to nine European countries…

Czech Republic The Czech Republic and Slovakia share a common past as Czechoslovakia, which parted in 1993. 23 years later, companies like LEO Pharma, Exeltis, and Wörwag are once again realising the synergies between these markets and adapting their strategies accordingly.   Regarding the Czech Republic and Slovakia is definitely beneficial, according to Renata Martinakova,…

Pharma The following chart shows the decline of the RX retail market in Italy since 2008, along with the 17% decrease in the average price of RX products per pack in 2015 from 2008. Because of the rise of generics, new chemical entities are often restricted to non-retail channels. Click here…

Pharma The following chart shows the leading innovators in Italian pharmaceuticals. Gilead leads the way with 135% growth, all of which comes from the hospitals sector. Click here to read more articles and interviews from Italy, and to download the latest free pharma report on the country.

Hungary Smaller pharma companies in Hungary are looking to new unconventional methods of OTC promotion to sidestep the country’s somewhat restrictive reimbursement scheme and compete with major players in the market. Especially in a market where the reimbursement scheme is highly restrictive, OTC has often been seen as a consistent and reliable area…

Women's H|alth “The right people at the right time at the right place with the right products” – The general manager for Exeltis Czech Republic & Slovakia reviews her strategy and key elements that led to 35 percent growth in her first two years at the Czech affiliate. Furthermore, she elaborates how…